KSPEN
KSSMN
ASSMN
Articles
- Page Path
- HOME > Ann Clin Nutr Metab > Volume 15(1); 2023 > Article
- Original article Effects of nutritional status and support on the survival of COVID-19 patients in a single tertiary-center intensive care unit in Korea: a case-control study
-
Na Gyeong Lee1,2
, Hye Jin Kim1,2, Ji Gyeong Kang2,3, Do Hyeon Jeon2,3, Mi Seung Kwak2,4, So Hyun Nam5 -
Annals of Clinical Nutrition and Metabolism 2023;15(1):30-37.
DOI: https://doi.org/10.15747/ACNM.2023.15.1.30
Published online: April 1, 2023
1Department of Pharmacy, Dong-A University Hospital, Busan, Korea
2Nutrition Support Team, Dong-A University Hospital, Busan, Korea
3Department of Nursing, Dong-A University Hospital, Busan, Korea
4Department of Nutrition and Dietetics, Dong-A University Hospital, Busan, Korea
5Department of surgery, Inje University Busan Paik Hospital, Busan, Korea
- Corresponding author: So Hyun Nam, email: d011029@naver.com
• Received: February 8, 2023 • Revised: March 16, 2023 • Accepted: March 23, 2023
© 2023 The Korean Society of Surgical Metabolism and Nutrition · The Korean Society for Parenteral and Enteral Nutrition
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
- 8 Views
- 0 Download
Abstract
-
Purpose It is important to understand the nutritional status of critically ill COVID-19 patients and to provide adequate associated support. We attempted to determine how nutritional status and the amount of nutritional support provided to critically ill patients affect their survival.
-
Methods We retrospectively reviewed the medical records of patients admitted to the intensive care unit of Dong-A University Hospital between January and December 2021. We divided the patients into survivors and those who died during COVID-19 treatment and compared and analyzed their clinical parameters, nutrition-related indicators, nutritional status, and nutritional support.
-
Results Of 70 patients reviewed, 57 survived. Mortality was higher in the older group (P=0.006). The patients who underwent ventilator, extracorporeal membrane oxygenation, or continuous renal replacement therapy showed higher mortality. Nutritional status at the time of admission and the nutritional requirements did not differ among patient groups. However, the actual amounts of calories (P<0.001) and protein (P=0.019) supplied were lower in the mortality group. Serum C-reactive protein level was higher (P=0.002) and serum albumin level was lower in those who did not survive (P<0.001) compared with surviving patients at discharge.
-
Conclusion We did not determine whether the initial nutritional status of patients with COVID-19 affected their survival due to various factors associated with the severity of the disease. However, given the similarities between disease severity and nutritional status at the time of admission, our results indicate that adequate nutritional support can contribute to survival in critically ill COVID-19 patients with pneumonia.
Introduction
COVID-19 is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1], which was first reported in Wuhan, China, in December 2019, and declared a global pandemic by the World Health Organization on March 2020 [2]. Patients infected with SARS-CoV-2 may complain of fever, cough, sore throat, fatigue, shortness of breath, and/or loss of appetite due to changes in taste and smell, and most patients recover over time with mild symptoms. However, some patients with underlying medical conditions and elderly patients are susceptible to COVID-19 pneumonia, which can progress to sepsis or acute respiratory distress syndrome, multiple organ failure, and death [3,-6]. Many countries have reported sudden deaths from COVID-19.
Approximately 5% of COVID-19 patients reportedly require intensive care [7]. While the risk factors affecting COVID-19 mortality remain uncertain, malnutrition resulting from long-term intensive care appears to reduce the mass and function of skeletal muscle. Subsequent malnutrition is associated with increase in morbidity and mortality [8].
Malnutrition is an imbalance in nutrition due to excessive or insufficient intake of energy, protein, and other nutrients. Among surgeons, it is well known that patients with malnutrition experience poor wound healing, higher rates of surgical complications, higher mortality, increased medical costs, and longer hospital stays than do those with good nutritional status.
Even in medical diseases, the influenza pandemic of 1918 showed that malnutrition was a risk factor for the severity and mortality of viral pneumonia [9]. The severity and transmission of pandemic influenza viruses depend on complex interactions among the virus, host, and external factors. Malnutrition is reportedly an important contributing factor in increasing the risk of mortality and the severity of viral pneumonia [9]. Even in patients with viral pneumonia, nutritional management during hospitalization, such as screening patients at risk of malnutrition at an early stage of hospitalization and providing appropriate nutritional support, is strongly recommended [10]. Research on factors related to various clinical features and severity associated with COVID-19 is underway worldwide, and malnutrition is expected to be related to mortality and complications in patients with pneumonia caused by COVID-19 [11].
We hypothesized that malnutrition can affect treatment outcomes in COVID-19 pneumonia in intensive care units (ICUs). This study is an attempt to identify how nutritional status and nutritional support affect the survival of critically ill COVID-19 patients.
Methods
This is a retrospective study conducted by collecting electronic medical records with deliberation and approval from the Institutional Review Board (IRB) of Dong-A University Hospital (approval number: DAUHIRB-23-016). Obtainment of informed consent was waived from the IRB.
It is a case-control study. It was described according to the STROBE statement available at: https://www.strobe-statement.org/.
We collected data on patients admitted to the ICU of Dong-A University Hospital for COVID-19 pneumonia from January to December 2021. COVID-19 was diagnosed through real-time polymerase chain reaction amplification tests. During the COVID-19 pandemic, Dong-A University Hospital was tasked with treating only critically ill patients. The decision to admit a patient to the ICU was made by specialists in infectious diseases and pulmonology. Most patients were transferred from a primary hospital to receive ventilator care, extracorporeal membrane oxygenation (ECMO), or continuous renal replacement therapy (CRRT), if needed.
We selected patients who received enteral nutrition (EN) and parenteral nutrition (PN) support after monitoring by a Nutrition Support Team. Our team evaluates the nutritional status of patients who have malnutrition or require EN and PN support, calculates their nutritional requirements, and establishes nutrition plans such as formulating and dosing nutritional support. If no physical measurements, such as height and weight, or no record from the Nutrition Support Team is available, the patient was excluded from the analysis.
Primary outcome variable is a nutritional status and the other variables are medications, ICU treatment, and clinical prognostic indicators.
We collected clinical parameters of age, sex, weight, height, underlying disease, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, PaO2/FiO2 ratio, serum C-reactive protein (CRP) level, and treatment provided. To compare nutritional factors between survivors and deceased patients, we analyzed nutritional status, body mass index (BMI), serum albumin level, and requirements for and supplied amounts of calories and protein through EN and PN support. Data on height and last known weight (i.e., before COVID-19 within the past 6 months) were collected by questioning patients during or shortly after their stay in the hospital.
Initial nutritional status assessments were classified based on the serum albumin level and percentage of ideal body weight (PIBW) according to the nutrition assessment guidelines of our hospital. A serum albumin of 3.5 g/dL or more and a PIBW of 90% or more were classified as adequate; a serum albumin level of 3.0–3.5 g/dL and a PIBW of 75%–90% were classified as mild malnutrition; a serum albumin level of 3.0–3.5 g/dL and a PIBW of 60%–75% were classified as modulate malnutrition; a serum albumin level less than 3.0 g/dL and a PIBW greater than 90% were classified as kwashiorkor; and a serum albumin level greater than 3.0 g/dL and a PIBW of no more than 80% were classified as marasmus.
There was no potential source of bias in selecting participants.
Since it is a retrospective study, sample size estimation was not done. All participants during the study period were selected according to the inclusion and exclusion criteria.
We summarized the data as mean±standard deviation for continuous variables and numbers and percentages for categorical variables. We analyzed categorical variables using chi-square and Fisher’s exact tests. Continuous variables were compared using a two-tailed t-test for normally distributed data using IBM SPSS version 27 for Windows (IBM Corp.). A P-value less than 0.05 was considered statistically significant.
Results
A total of 70 patients was included in the study, of whom 57 (81.4%) were discharged from the hospital after COVID-19 treatment and 13 (18.6%) died. All patients able to ingest food orally were fed a high-protein diet. EN or PN support was started an average of 3.2 days after admission to the ICU. During an average of 20.4 days of hospitalization, EN or PN support was supplied for an average of 12.5 days.
Basic information and clinical characteristics of the study subjects are presented in Table 1. The average age was 59.8±17.6 years in the survival group and 74.2±10.6 years in the deceased group; the difference was statistically significant (P=0.006). There was no statistically significant difference between the two groups in terms of sex (P=0.753) and height (P=0.511). The weights at hospitalization (P=0.766) and at discharge (P=0.493) were lower in the death group but showed no significant difference. BMI was also lower in the death group, but there was no significant difference between the two groups (P=0.676).
With respect to underlying diseases, 13 patients (18.6%) had diabetes mellitus, 9 (12.9%) had hypertension, 3 (4.3%) had a cerebral infarction, 2 (2.9%) had cancer, and there were 2 cases of myocardial infarction (2.9%) and 2 cases of atrial fibrillation (2.9%). Patients with 3 additional comorbidities showed a higher mortality rate (Table 1).
Clinical prognosis indicators
The two groups were compared by examining APACHE II scores, PaO2/FiO2 ratios at hospitalization, and CRP levels at hospitalization and discharge (Table 2). APACHE II score was higher in the group of patients who died, but the difference was not statistically significant (P=0.944). A total of 37.1% of patients received high-flow oxygen therapy or mechanical ventilation at the time of admission, and the average PaO2/FiO2 was 237.3. The PaO2/FiO2 ratio at admission (P=0.670) and CRP level at admission (P=0.102) were also higher in the deceased patients, but not to a significant degree. At discharge, CRP level was significantly higher in the deceased group than in the survival group (P=0.002).
Decisions about whether to administer drugs (dexamethasone, remdesivir, regdanvimab, or tocilizumab) to treat COVID-19 or top use a ventilator, ECMO, or CRRT were described and compared between the two groups (Table 3). The proportions of patients prescribed dexamethasone (P=0.336), remdesivir (P=0.763), regdanvimab (P>0.999), and tocilizumab (P=0.123) to treat COVID-19 were not significantly different between the two groups. The proportion of patients on ventilators was significantly higher in the death group than in the survival group (P=0.012). The proportion of patients with ECMO and CRRT was significantly higher in the death group than in the survival group (P<0.001).
Nutritional status and support
The nutritional status of patients was based on serum albumin level and PIBW at hospitalization (Table 4). There was no significant difference in nutritional status at the onset of hospitalization between the two groups (P=0.280). The amounts of calories and protein supplied through oral, EN, and PN support were calculated, and the calorie and protein requirements per kilogram of reference weight were calculated and compared (Table 5). There was no significant difference between the two groups in calorie and protein requirements (P=0.163 and P=0.408, respectively). The total calorie supply was significantly lower in the deceased group (P<0.001), as was the total protein supply (P=0.019). Daily calories and protein supplied per weight (P=0.002 and P=0.015, respectively) were significantly lower in the deceased group than in the survival group. Serum albumin level at the time of hospitalization was not significantly different between the two groups (P=0.205), but serum albumin level at discharge was significantly lower among non-survivors (P<0.001; Table 6).
Discussion
In this study, we investigated only patients with critical illness requiring ICU hospitalization. These patients were assumed to be a relatively homogeneous group among those infected with SARS-CoV-2, and nutritional status and requirements were assessed according to a common protocol. The average duration of admission to the ICU for the patients in this study was 20.4 days, and malnutrition was observed in all but 15 patients, who had good nutritional status at admission. Although the nutritional status at the time of hospitalization was similar between survivors and non-survivors, the amount of nutrients actually supplied was lower in the non-survivor group. The American Society for Parenteral and Enteral Nutrition (ASPEN), which set guiding principles for COVID-19 management, recommends an energy goal of 15–20 kcal/kg actual body weight (ABW)/day, which should provide 70% to 80% of a patient’s energy requirements, and a protein goal of 1.2–2 g/kg ABW/day [7]. ESPEN expert statements and practical guidance for nutritional management of individuals infected with SARS-CoV-2 recommend an energy intake of 27–30 kcal/kg of body weight/day and a protein intake of at least 1 g/kg of body weight/day [8]. In this study, the amounts of calories and protein supplied to patients who died were less than those recommended by the guidelines. This can be interpreted in several ways.
Critically ill patients are prone to deteriorating nutritional status and can quickly enter a catabolic state due to complex metabolic changes in cytokines and stress hormones. Hemodynamic instability due to sepsis, ventilator care due to respiratory complications, and application of ECMO or CRRT are risk factors that hinder adequate nutritional support. In addition, for patients in a state of shock, the use of inotropic agents may be limited to ensure sufficient nutrition. The deceased group was older on average than the survivors, their CRP level was higher at discharge, and the proportion of patients who used a ventilator, ECMO, or CRRT during treatment was also high. Although the patients were in a recovery period and required sufficient nutritional support, oral intake was often difficult due to difficulty swallowing after removing the ventilator. This was accompanied by a loss of taste and smell and a loss of appetite. To minimize deterioration of nutritional status, sufficient calories and protein must be supplied to severely ill COVID-19 patients during hospitalization [8,12].
Because an immunocompromised state can be a risk factor for respiratory infections, adequate nutritional support and maintaining adequate nutritional status are believed to be crucial for ensuring optimal immunity against infection [13]. Although mortality rates are decreasing due to the development of vaccines and new pharmaceutical treatments, clinical research on COVID-19 may continue to reveal the nature of COVID-19 and protect populations against the emergence of mutant viruses. This study represents an attempt to identify risk factors that affect the survival of critically ill patients with COVID-19 and demonstrates the benefits of adequate nutritional support.
Kananen et al. [14] reported that a low BMI was associated with an increase in the mortality rate among elderly patients with COVID-19. In a large cohort study of COVID-19 patients, Bouziotis et al. [15] reported that overweight patients had a significantly lower risk of in-hospital death compared with those who were underweight. This indicates that a nutritional status outside the standard range, rather than weight itself, is a risk factor. Body measurements, such as body weight, are used as an index to indicate imbalances in calorie and protein intake and consumption over a certain period of time. They are used to diagnose chronic caloric and protein intake deficiencies, sluggish growth, and overweight and can also be used to evaluate the response to nutritional treatment. It is important to accurately measure weight when evaluating nutritional status during hospitalization. Although no significant differences were found in weight and BMI at admission and discharge, both tended to be lower in the deceased group than in the surviving group. However, it was difficult to interpret the results in critically ill patients due to difficulty accurately measuring patient weights due to their clinical conditions as well as water retention caused by stress.
Among the nutrients that affect immune function, vitamin D, magnesium, vitamin B12, and vitamin C have been reported to significantly reduce the proportion of severely ill patients and prolong survival [13,16,-19]. Although immune-boosting nutrients, such as glutamine, selenium, and zinc, reportedly have antiviral effects [13,20,21], appropriate supply levels, methods, types, and administration periods have yet to be established. European Society for Clinical Nutrition and Metabolism guidelines suggest providing the recommended daily amounts of vitamins and trace elements [8]. No blood measurements of trace elements and vitamin D were conducted for this study. However, the total calories and protein mass supplied during hospitalization appeared to be lower in the deceased group compared with the survival group, indicating insufficient nutritional support.
The serum albumin level, which can be used as an index of nutritional status, may be affected by an inflammatory response. In previous studies, serum albumin level was not considered an appropriate indicator of malnutrition [22]. However, Eckart et al. [23] reported that serum albumin level can be used to evaluate nutritional status in patients with acute disease conditions, regardless of the presence of inflammation. Chronic protein deficiency, even when there is adequate intake of non-protein calories, can lead to significant hypoalbuminemia. Body weight and serum albumin concentrations are the minimum objective data needed to substantiate clinical observations and establish reference values for monitoring. The cost-effectiveness of adding biochemical markers other than albumin has not been established [24]. We used serum albumin level to assess the nutritional status of patients, finding a lower level lower in the mortality group.
Considering that multiple factors affect the severity of COVID-19, inadequate nutritional support alone is not responsible for patient death. However, there was no significant difference between the two groups in the type and number of underlying diseases, nutritional status, and albumin and CRP levels at the time of admission. These results suggest that sufficient nutritional support during hospitalization in the ICU can contribute to the survival of critically ill patients with COVID-19. Calculations of actual nutritional indicators and supplying nutritional requirements in a relatively uniform group would be worthy of research resources.
However, this study had several limitations. Measuring ABW as a reference to assess nutritional status was difficult because many patients were bedridden. In addition, when calculating caloric requirements, the calculation method we followed (according to our guidelines) did not use an indirect calorimeter.
The result of this study may be able to generalized to case of COVID-19 patients in another hospital in Korea.
Further studies are required to identify additional factors that affect patient survival.
Due to various factors affecting the severity of COVID-19, it was not possible to determine whether the nutritional status of critically ill patients with COVID-19 at hospitalization had an effect on survival. Adequate nutritional support during ICU stays may contribute to the survival of critically ill patients with COVID-19. The severity of COVID-19, the unstable hemodynamic status of the deceased group, and difficulties providing active nutritional support are potential influences.
Acknowledgments
None.
Authors’ contribution
Conceptualization: NGL, SHN. Data curation: NGL, HJK, JGK, DHJ, MSK. Formal analysis: NGL, SHN. Investigation: NGL, HJK, JGK, DHJ, MSK. Methodology: SHN. Project administration: SHN. Resources: NGL, SHN. Software: NGL, SHN. Supervision: SHN. Validation: SHN. Visualization: NGL, SHN. Writing – original draft: NGL. Writing – review & editing: SHN.
Conflict of interest
So Hyun Nam is an editorial board member of the journal, but was not involved in the review process of this manuscript. Otherwise, there is no conflict of interest to declare.
Funding
None.
Data availability
Contact the corresponding author for data availability.
Supplementary materials
None.
Table 1
Baseline characteristics of the study population
| Variable |
Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| Age (yr) | 62.49±17.4 | 59.8±17.6 | 74.2±10.6 | 0.006* |
| Sex | 0.753 | |||
| Male | 46 (65.7) | 38 (66.7) | 8 (61.5) | |
| Female | 24 (34.3) | 19 (33.3) | 5 (38.5) | |
| Height (cm) | 166.0±10.1 | 165.6±10.6 | 167.8±7.4 | 0.511 |
| Weight at admission (kg) | 66.9±15.2 | 67.1±15.5 | 65.7±14.4 | 0.766 |
| Weight at discharge (kg) | 66.2±14.5 | 67.2±15.4 | 62.5±10.5 | 0.493 |
| Body mass index (kg/m2) | 24.9±3.9 | 24.1±3.9 | 23.6±3.9 | 0.676 |
| Underlying disease | ||||
| Hypertension | 9 (12.9) | 5 (8.8) | 4 (30.8) | 0.055 |
| Diabetes mellitus | 13 (18.6) | 8 (14.0) | 5 (38.5) | 0.056 |
| Chronic kidney disease | 1 (1.4) | 0 | 1 (7.7) | 0.186 |
| Cancer | 2 (2.9) | 2 (3.5) | 0 | >0.999 |
| Asthma | 1 (1.4) | 1 (1.8) | 0 | >0.999 |
| Cerebral infarction | 3 (4.3) | 3 (5.3) | 0 | >0.999 |
| Myocardial infarction | 2 (2.9) | 1 (1.8) | 1 (7.7) | 0.339 |
| Liver cirrhosis | 1 (1.4) | 1 (1.8) | 0 | >0.999 |
| Atrial fibrillation | 2 (2.9) | 2 (3.5) | 0 | >0.999 |
| Etc. | 13 (18.6) | 13 (22.8) | 0 | >0.999 |
Table 2
Clinical prognostic indicators
| Variable |
Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| APACHE II score | 14.8±7.7 | 14.7±7.1 | 15.0±10.3 | 0.944 |
| PaO2/FiO2 ratio at admission | 237.3±145.5 | 233.7±139.1 | 252.9±176.1 | 0.670 |
| Median (IQR) | 199.3 (128.0–306.4) | 212 (141.8–335.0) | ||
| CRP at admission (mg/dL) | 10.2±6.8 | 13.6±5.4 | 0.102 | |
| CRP at discharge (mg/dL) | 1.5±2.5 | 7.2±5.1 | 0.002** |
Table 3
Comparison of COVID-19 medications and intensive care unit treatments
| Variable |
Total (n=70) |
Survival (n=57) |
Deceased (n =13) |
P-value |
|---|---|---|---|---|
| Medicationsa | ||||
| Dexamethasone | 62 (88.6) | 49 (86.0) | 13 (100) | 0.336 |
| Remdesivir | 36 (51.4) | 30 (52.6) | 6 (46.2) | 0.763 |
| Regdanvimab | 2 (2.9) | 2 (3.5) | 0 | >0.999 |
| Tocilizumab | 33 (47.1) | 24 (42.1) | 9 (69.2) | 0.123 |
| ICU treatment | ||||
| Ventilator | 26 (37.1) | 17 (29.8) | 9 (69.2) | 0.012* |
| ECMO | 11 (15.7) | 3 (5.3) | 8 (61.5) | <0.001*** |
| CRRT | 8 (11.4) | 1 (1.8) | 7 (53.8) | <0.001*** |
Table 4
Comparison of nutritional status at admission
Table 5
Comparison of nutritional requirements and nutrition supply status
| Variable |
Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| Nutritional requirement | ||||
| Calorie (kcal) | 1,685.9±347.4 | 1,721.3±342.2 | 1,556.2±349.6 | 0.163 |
| Protein (g) | 79.3±15.4 | 80.2±13.9 | 76.1±18.7 | 0.408 |
| Nutrition supply | ||||
| Total calorie (kcal) | 1,420.2±382.4 | 1,495.0±387.1 | 1,145.8±201.7 | <0.001*** |
| Total protein (g) | 62.4±22.4 | 64.8±24.0 | 53.2±11.0 | 0.019* |
| Calorie/BW (kcal/kg) | 21.8±6.8 | 22.9±7.0 | 17.8±3.9 | 0.002** |
| Protein/BW (g/kg) | 1.0±0.3 | 1.0±0.3 | 0.8±0.2 | 0.015* |
Table 6
Comparison of serum albumin level
| Variable |
Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| Serum albumin level | ||||
| At admission (g/dL) | 3.4±0.5 | 3.4±0.5 | 3.2±0.4 | 0.205 |
| At discharge (g/dL) | 3.1±0.5 | 3.2±0.4 | 2.6±0.2 | <0.001*** |
- 1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. ArticlePMC
- 2. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157-60.PubMedPMC
- 3. Fedele D, De Francesco A, Riso S, Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: an overview. Nutrition 2021;81:111016. ArticlePubMed
- 4. Cawood AL, Walters ER, Smith TR, Sipaul RH, Stratton RJ. 2020;A review of nutrition support guidelines for individuals with or recovering from COVID-19 in the community. Nutrients 12:3230.ArticlePubMedPMC
- 5. Brugliera L, Spina A, Castellazzi P, Cimino P, Arcuri P, Negro A, et al. Nutritional management of COVID-19 patients in a rehabilitation unit. Eur J Clin Nutr 2020;74:860-3. ArticlePubMedPMCPDF
- 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. PubMedPMC
- 7. Martindale R, Patel JJ, Taylor B, Arabi YM, Warren M, McClave SA. Nutrition therapy in critically ill patients with Coronavirus disease 2019. JPEN J Parenter Enteral Nutr 2020;44:1174-84. ArticlePubMedPMCPDF
- 8. Barazzoni R, Bischoff SC, Breda J, Wickramasinghe K, Krznaric Z, Nitzan D, et al. endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr 2020;39:1631-8. ArticlePubMedPMC
- 9. Short KR, Kedzierska K, van de Sandt CE. Back to the future: lessons learned from the 1918 influenza pandemic. Front Cell Infect Microbiol 2018;8:343.ArticlePubMedPMC
- 10. Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr 2003;22:235-9. ArticlePubMed
- 11. Bedock D, Bel Lassen P, Mathian A, Moreau P, Couffignal J, Ciangura C, et al. Prevalence and severity of malnutrition in hospitalized COVID-19 patients. Clin Nutr ESPEN 2020;40:214-9. ArticlePubMedPMC
- 12. Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr 2019;38:48-79. ArticlePubMed
- 13. Im JH, Je YS, Baek J, Chung MH, Kwon HY, Lee JS. Nutritional status of patients with COVID-19. Int J Infect Dis 2020;100:390-3. ArticlePubMedPMC
- 14. Kananen L, Eriksdotter M, Boström AM, Kivipelto M, Annetorp M, Metzner C, et al. Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19. Clin Nutr 2022;41:2973-9. ArticlePubMed
- 15. Bouziotis J, Arvanitakis M, Preiser JC. ISARIC Clinical Characterisation Group. Association of body mass index with COVID-19 related in-hospital death. Clin Nutr 2022;41:2924-6. ArticlePubMedPMC
- 16. Notz Q, Herrmann J, Schlesinger T, Kranke P, Sitter M, Helmer P, et al. Vitamin D deficiency in critically ill COVID-19 ARDS patients. Clin Nutr 2022;41:3089-95. ArticlePubMed
- 17. Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S, et al. NUTRI-COVID19 IRCCS San Matteo Pavia Collaborative Group. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin Nutr 2021;40:2469-72. ArticlePubMed
- 18. Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition 2020;79-80:111017. PubMed
- 19. Majidi N, Rabbani F, Gholami S, Gholamalizadeh M, BourBour F, Rastgoo S, et al. 2021;The effect of vitamin C on pathological parameters and survival duration of critically ill Coronavirus disease 2019 patients: a randomized clinical trial. Front Immunol 12:717816. ArticlePubMedPMC
- 20. Mohajeri M, Horriatkhah E, Mohajery R. 2021;The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study. Inflammopharmacology 29:1769-76; Erratum in: Inflammopharmacology 2022;30:353. ArticlePubMedPMCPDF
- 21. Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, et al. Zinc and respiratory tract infections: perspectives for COVID-19 (review). Int J Mol Med 2020;46:17-26. ArticlePubMedPMC
- 22. Gehring N, Imoberdorf R, Wegmann M, Rühlin M, Ballmer PE. Serumalbumin--a qualified parameter to determine the nutritional status? Swiss Med Wkly 2006;136:664-9. ArticlePubMed
- 23. Eckart A, Struja T, Kutz A, Baumgartner A, Baumgartner T, Zurfluh S, et al. Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. Am J Med 2020;133:713-22.e7. ArticlePubMed
- 24. Kim JT, Park HJ, Kim HJ, Kim SH, Kim YJ, Kim JH, et al. In: Kim JT, Park HJ, editors. 2021. Nutrition search and assessment. Clinical nutrition. Korea Hospital Pharmaceutical Education & Research Center; p. 101-16.
References
Figure & Data
REFERENCES
Citations
Citations to this article as recorded by 
Cite
XML Download- Related articles
-
- Early nutritional support for inpatients reduces admission rates to intensive care units in Korea: a single-center case-control study
- Comparative assessment of nutritional characteristics of critically ill patients at admission and discharge from the neurosurgical intensive care unit in Korea: a comparison study
- Comparison of a volume-based feeding protocol with standard feeding for trauma patients in intensive care units in Korea: a retrospective cohort study
Effects of nutritional status and support on the survival of COVID-19 patients in a single tertiary-center intensive care unit in Korea: a case-control study
Effects of nutritional status and support on the survival of COVID-19 patients in a single tertiary-center intensive care unit in Korea: a case-control study
Baseline characteristics of the study population
| Variable | Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| Age (yr) | 62.49±17.4 | 59.8±17.6 | 74.2±10.6 | 0.006 |
| Sex | 0.753 | |||
| Male | 46 (65.7) | 38 (66.7) | 8 (61.5) | |
| Female | 24 (34.3) | 19 (33.3) | 5 (38.5) | |
| Height (cm) | 166.0±10.1 | 165.6±10.6 | 167.8±7.4 | 0.511 |
| Weight at admission (kg) | 66.9±15.2 | 67.1±15.5 | 65.7±14.4 | 0.766 |
| Weight at discharge (kg) | 66.2±14.5 | 67.2±15.4 | 62.5±10.5 | 0.493 |
| Body mass index (kg/m2) | 24.9±3.9 | 24.1±3.9 | 23.6±3.9 | 0.676 |
| Underlying disease | ||||
| Hypertension | 9 (12.9) | 5 (8.8) | 4 (30.8) | 0.055 |
| Diabetes mellitus | 13 (18.6) | 8 (14.0) | 5 (38.5) | 0.056 |
| Chronic kidney disease | 1 (1.4) | 0 | 1 (7.7) | 0.186 |
| Cancer | 2 (2.9) | 2 (3.5) | 0 | >0.999 |
| Asthma | 1 (1.4) | 1 (1.8) | 0 | >0.999 |
| Cerebral infarction | 3 (4.3) | 3 (5.3) | 0 | >0.999 |
| Myocardial infarction | 2 (2.9) | 1 (1.8) | 1 (7.7) | 0.339 |
| Liver cirrhosis | 1 (1.4) | 1 (1.8) | 0 | >0.999 |
| Atrial fibrillation | 2 (2.9) | 2 (3.5) | 0 | >0.999 |
| Etc. | 13 (18.6) | 13 (22.8) | 0 | >0.999 |
Values are presented as mean±standard deviation or number (%).
*P<0.05.
Clinical prognostic indicators
| Variable | Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| APACHE II score | 14.8±7.7 | 14.7±7.1 | 15.0±10.3 | 0.944 |
| PaO2/FiO2 ratio at admission | 237.3±145.5 | 233.7±139.1 | 252.9±176.1 | 0.670 |
| Median (IQR) | 199.3 (128.0–306.4) | 212 (141.8–335.0) | ||
| CRP at admission (mg/dL) | 10.2±6.8 | 13.6±5.4 | 0.102 | |
| CRP at discharge (mg/dL) | 1.5±2.5 | 7.2±5.1 | 0.002 |
Values are presented as mean±standard deviation.
APACHE II = Acute Physiology and Chronic Health Evaluation II; CRP = C-reactive protein.
**P<0.01.
Comparison of COVID-19 medications and intensive care unit treatments
| Variable | Total (n=70) |
Survival (n=57) |
Deceased (n =13) |
P-value |
|---|---|---|---|---|
| Medications |
||||
| Dexamethasone | 62 (88.6) | 49 (86.0) | 13 (100) | 0.336 |
| Remdesivir | 36 (51.4) | 30 (52.6) | 6 (46.2) | 0.763 |
| Regdanvimab | 2 (2.9) | 2 (3.5) | 0 | >0.999 |
| Tocilizumab | 33 (47.1) | 24 (42.1) | 9 (69.2) | 0.123 |
| ICU treatment | ||||
| Ventilator | 26 (37.1) | 17 (29.8) | 9 (69.2) | 0.012 |
| ECMO | 11 (15.7) | 3 (5.3) | 8 (61.5) | <0.001 |
| CRRT | 8 (11.4) | 1 (1.8) | 7 (53.8) | <0.001 |
Values are presented as number (%).
ICU = intensive care unit; ECMO = extracorporeal membrane oxygenation; CRRT = continuous renal replacement therapy.
aMedications available at Dong-A University Hospital for COVID-19 treatment as of 2021.
*P<0.05 and ***P<0.001.
Comparison of nutritional status at admission
| Variable | Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| Normal | 15 (21.4) | 14 (24.6) | 1 (7.7) | 0.280 |
| Abnormal | ||||
| Mild malnutrition | 32 (45.7) | 26 (45.6) | 6 (46.2) | |
| Moderate malnutrition | 7 (10.0) | 5 (8.8) | 2 (15.4) | |
| Severe malnutrition | 1 (1.4) | 1 (1.7) | 0 | |
| Kwashiorkor | 10 (14.3) | 6 (10.5) | 4 (30.7) | |
| Marasmus | 5 (7.2) | 5 (8.8) | 0 |
Values are presented as number (%).
Comparison of nutritional requirements and nutrition supply status
| Variable | Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| Nutritional requirement | ||||
| Calorie (kcal) | 1,685.9±347.4 | 1,721.3±342.2 | 1,556.2±349.6 | 0.163 |
| Protein (g) | 79.3±15.4 | 80.2±13.9 | 76.1±18.7 | 0.408 |
| Nutrition supply | ||||
| Total calorie (kcal) | 1,420.2±382.4 | 1,495.0±387.1 | 1,145.8±201.7 | <0.001 |
| Total protein (g) | 62.4±22.4 | 64.8±24.0 | 53.2±11.0 | 0.019 |
| Calorie/BW (kcal/kg) | 21.8±6.8 | 22.9±7.0 | 17.8±3.9 | 0.002 |
| Protein/BW (g/kg) | 1.0±0.3 | 1.0±0.3 | 0.8±0.2 | 0.015 |
Values are presented as mean±standard deviation.
BW = body weight.
*P<0.05, **P<0.01, and ***P<0.001.
Comparison of serum albumin level
| Variable | Total (n=70) |
Survival (n=57) |
Deceased (n=13) |
P-value |
|---|---|---|---|---|
| Serum albumin level | ||||
| At admission (g/dL) | 3.4±0.5 | 3.4±0.5 | 3.2±0.4 | 0.205 |
| At discharge (g/dL) | 3.1±0.5 | 3.2±0.4 | 2.6±0.2 | <0.001 |
Values are presented as mean±standard deviation.
***P<0.001.
Table 1
Baseline characteristics of the study population
Values are presented as mean±standard deviation or number (%). *P<0.05.
Table 2
Clinical prognostic indicators
Values are presented as mean±standard deviation. APACHE II = Acute Physiology and Chronic Health Evaluation II; CRP = C-reactive protein. **P<0.01.
Table 3
Comparison of COVID-19 medications and intensive care unit treatments
Values are presented as number (%). ICU = intensive care unit; ECMO = extracorporeal membrane oxygenation; CRRT = continuous renal replacement therapy. aMedications available at Dong-A University Hospital for COVID-19 treatment as of 2021. *P<0.05 and ***P<0.001.
Table 4
Comparison of nutritional status at admission
Values are presented as number (%).
Table 5
Comparison of nutritional requirements and nutrition supply status
Values are presented as mean±standard deviation. BW = body weight. *P<0.05, **P<0.01, and ***P<0.001.
Table 6
Comparison of serum albumin level
Values are presented as mean±standard deviation. ***P<0.001.
